Corona Remedies IPO Review & Recommendations

Corona Remedies IPO Peer Comparison

Corona Remedies Ltd. peer comparison with similar listed entities. (As on March 31, 2025)

Source for CORONA Remedies Limited:

Notes:

1. P/E Ratio has been computed based on the closing market price of equity shares on Nov 28, 2025, divided by the Diluted EPS.
2. Return on net worth is the restated profit attributable to owners of the Company divided by the net worth at the end of the period/year.
3. Net asset value per equity share as at a period/year represents net worth at the end of the period/year divided by the weighted average outstanding equity shares considered for EPS as the end of the period/year.
4. J. B. Chemicals & Pharmaceuticals Limited has announced a stock split from ₹2.00 per equity share to ₹1.00 per equity share with the ex-split date on September 18, 2023. Accordingly, Net asset value per equity share has been adjusted to reflect the stock split.